Key stories from global financial media overnight and this morning include:

1. Trump Gives Iran 10-15 Days to Reach an Agreement When questioned by reporters about whether a deadline had been set for Iran, former President Trump stated he would allow Iran a maximum of "10 to 15 days" to reach a deal. "I think that should be enough, 10 to 15 days, that's about the maximum," Trump said, adding, "We will either have a deal or we will have a result one way or the other."

2. Alien Topic Sparks Controversy; Trump Accuses Obama of Leaking Classified Information Former US President Trump accused his predecessor, Barack Obama, of leaking classified information during a recent podcast discussion about aliens. "He leaked classified information, he shouldn't have done that," Trump told reporters aboard Air Force One on Thursday. When pressed on whether this meant aliens are real, Trump said he "doesn't know if they're real or not."

3. Amazon.com Overtakes Wal-Mart to Become Global Sales Leader Amazon.com has surpassed Wal-Mart to become the world's highest-grossing company, ending Wal-Mart's 13-year reign at the top. Amazon.com's sales reached $717 billion in 2025. Wal-Mart, which had held the top spot for over a decade, reported sales of $713 billion for the same period. Although the two companies are major competitors in consumer retail, Amazon.com's revenue growth in cloud computing, advertising, and other businesses helped it achieve this overtake.

4. Johnson & Johnson Explores Sale of Orthopedics Unit, Valuation Could Exceed $20 Billion According to informed sources, Johnson & Johnson is preparing to sell its planned spin-off orthopedics business unit, with large private equity firms already showing interest in a potential transaction. The DePuy Synthes business could be valued at over $20 billion in a sale. Johnson & Johnson is already compiling relevant documents and financial materials for DePuy Synthes to meet with potential buyers in the coming weeks. Several major private equity firms are reportedly considering a joint acquisition of the business. DePuy Synthes manufactures devices for hip and knee replacements and generated $9.3 billion in sales last year. The unit may also attract interest from competing medical device companies.

5. JPMorgan European Branch Fined €12.18 Million by ECB for Misreporting Capital Requirements The European Central Bank stated in a declaration on Thursday that JPMorgan's European branch has been fined €12.18 million ($14.32 million) for misreporting capital requirements due to incorrect calculations of risk-weighted assets. The ECB said that between 2019 and 2024, the bank reported risk-weighted assets at a lower level than required; this occurred because the bank misclassified corporate risk exposures for 15 consecutive quarters and applied a lower credit risk weighting than stipulated by banking rules. The ECB added that the bank also improperly excluded certain transactions when calculating risk-weighted assets, a decision that could be challenged in the Court of Justice of the European Union.

6. BioNTech Sues Moderna for Infringing COVID-19 Vaccine Patents German biopharmaceutical company BioNTech sued Moderna in Delaware federal court on Thursday, alleging that Moderna's COVID-19 vaccine, mNEXSPIKE, infringes patents related to BioNTech and Pfizer's competing vaccine, Comirnaty. The lawsuit claims that Moderna's next-generation COVID-19 vaccine, mNEXSPIKE, which received FDA approval in 2025, infringes on BioNTech's rights concerning technology used to simplify mRNA vaccine design. This technology allows for vaccinating patients with lower doses.